India’s leading pharmaceutical companies are hoping to squeeze billions in additional sales out of gaps in the U.S. market by developing niche treatments for ailments ignored by industry leaders.
from WSJ.com: US Business http://ift.tt/1Nyfl1e
via IFTTT
No comments:
Post a Comment